Loading…

Prognostic value of perfusion cardiovascular magnetic resonance with adenosine triphosphate stress in stable coronary artery disease

Adenosine triphosphate (ATP) has been predominantly used in the Asia-Pacific region for stress perfusion cardiovascular magnetic resonance (CMR). We evaluated the prognosis of patients stressed using ATP, for which there are no current data. We performed a retrospective longitudinal study from Janua...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiovascular magnetic resonance 2021-06, Vol.23 (1), p.75-11, Article 75
Main Authors: Ng, Ming-Yen, Chin, Chi Yeung, Yap, Pui Min, Wan, Eric Yuk Fai, Hai, JoJo Siu Han, Cheung, Stephen, Tse, Hung Fat, Bucciarelli-Ducci, Chiara, Pennell, Dudley John, Yiu, Kai-Hang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adenosine triphosphate (ATP) has been predominantly used in the Asia-Pacific region for stress perfusion cardiovascular magnetic resonance (CMR). We evaluated the prognosis of patients stressed using ATP, for which there are no current data. We performed a retrospective longitudinal study from January 2016 to December 2020 and included 208 subjects with suspected obstructive coronary artery disease (CAD) who underwent ATP stress perfusion CMR. An inducible stress perfusion defect was defined as a subendocardial dark rim involving ≥ 1.5 segments that persisted for ≥ 6 beats during stress but not at rest. The primary outcome measure was a composite of major adverse cardiovascular events (MACE) including (1) cardiac death, (2) nonfatal myocardial infarction, (3) cardiac hospitalization, (4) late coronary revascularization. We compared outcomes in patients with and without perfusion defect using Kaplan-Meier and log rank tests. Significant predictors of MACE were identified using multivariable Cox regression analysis. Median follow-up was 3.3 years. Patients with no stress perfusion defect had a lower incidence of MACE (p 
ISSN:1097-6647
1532-429X
1532-429X
DOI:10.1186/s12968-021-00770-z